XM does not provide services to residents of the United States of America.

Banks, healthcare stocks drag Australian shares lower; ASIC sues NAB



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>Banks, healthcare stocks drag Australian shares lower; ASIC sues NAB</title></head><body>

Nov 18 (Reuters) -Australian shares fell on Monday, dragged down by financial and healthcare stocks, while the country's corporate watchdog sued National Australia Bank for breach of financial hardship laws.

The S&P/ASX 200 index .AXJO fell 0.2% to 8,270.5 by 0014 GMT after two straight sessions of gains.

Interest rate-sensitive financials .AXFJ declined 0.8% after two straight sessions of gains, with the "big four" banks down between 0.6% and 1.8%.

The Australian Securities and Investments Commission launched civil penalty proceedings against National Australia Bank NAB.AX for failing to respond to hundreds of financial hardship applications within the legally mandated time frame.

Shares of the country's second-largest lender fell as much as 1.9%.

Healthcare stocks .AXHJ declined 1.1% with CSL CSL.AX, the country's priciest stock, down 2%.

U.S. President-elect Donald Trump said on Thursday he has selected Robert F. Kennedy Jr., a known anti-vaxxer, to lead the Department of Health and Human Services.

IT stocks .AXIJ lost 1.1%. The U.S. Dow Jones Industrial Average .DJI fell 0.70% on Friday. The S&P 500 .SPX lost 1.32%, while the Nasdaq .IXIC lost 2.24%.

In corporate news, Resolute Mining RSG.AX said it would pay $160 million to Mali's government to help resolve a tax dispute after the West African country detained its CEO Terence Holohan and two other employees this month.

Resolute shares fell as much as 14.3%, hitting their lowest level since March 1.

Capping the losses on the benchmark stock index, heavyweight miners .AXMM climbed 0.9% despite a dip in iron ore prices.

Sector giants BHP Group BHP.AX rose 0.5%, while Rio Tinto RIO.AX gained 1.2%.

Energy stocks .AXEJ climbed 1%, with Woodside Energy WDS.AX and Santos STO.AX both trading largely flat.

In New Zealand, the benchmark S&P/NZX 50 index .NZ50 fell 0.2% to 12,656.2, as of 0014 GMT.



Reporting by Rajasik Mukherjee in Bengaluru; Editing by Subhranshu Sahu

For more information on DIARIES & DATA: U.S. earnings diary RESF/US Wall Street Week Ahead .N/O Global Economy Week Ahead DATA/ ................................................................ For latest top breaking news across all markets NEWS1
</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.